Jiehan Li

1.0k total citations
39 papers, 642 citations indexed

About

Jiehan Li is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Jiehan Li has authored 39 papers receiving a total of 642 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 13 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Jiehan Li's work include Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (8 papers) and MicroRNA in disease regulation (5 papers). Jiehan Li is often cited by papers focused on Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (8 papers) and MicroRNA in disease regulation (5 papers). Jiehan Li collaborates with scholars based in China, United States and Hong Kong. Jiehan Li's co-authors include Vassilios Papadopoulos, Veera Vihma, Amani Batarseh, Enrico Campioli, Martin Wabitsch, Edward Daly, Yingjie Zhang, Feng Wang, Chuchu Zhang and Lingling Zhang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

Jiehan Li

34 papers receiving 639 citations

Peers

Jiehan Li

PHYSI

EPIDE

EDM

Gelei Xiao China

Xianning Zhang China

Christopher J. Pelham United States

Franziska Greulich Germany

Lucia Longhitano Italy

F. Scatena Italy

Alberto Zullo Italy

Fei Lan China

Noriko Miyamoto Japan

Jianda Dong China

Gelei Xiao China

Jiehan Li

279 ×1.0

161 ×1.3

126 ×1.5

PHYSI

60 ×0.8

EPIDE

48 ×0.6

EDM

Citations per year, relative to Jiehan Li Jiehan Li (= 1×) peers Gelei Xiao

Countries citing papers authored by Jiehan Li

Since Specialization

Citations

This map shows the geographic impact of Jiehan Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiehan Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiehan Li more than expected).

Fields of papers citing papers by Jiehan Li

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiehan Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiehan Li. The network helps show where Jiehan Li may publish in the future.

Co-authorship network of co-authors of Jiehan Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jiehan Li. A scholar is included among the top collaborators of Jiehan Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiehan Li. Jiehan Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Jing, et al.. (2026). Dual-faced PUMA in CRC: A cytoplasmic autophagy repressor and mitochondrial mitophagy promoter. Cellular Signalling. 140. 112363–112363.

Li, Jiehan, Nannan Liu, Ning Ding, et al.. (2025). Unraveling the miR-144-3p/PUMA pathway: a novel regulator of FDX1-mediated cuproptosis in colorectal cancer. Cellular Oncology. 48(6). 1693–1710. 1 indexed citations

Li, Shanshan, Zhiyu Wang, Junting Zhou, et al.. (2025). Unraveling the Role of the Wnt Pathway in Hepatocellular Carcinoma: From Molecular Mechanisms to Therapeutic Implications. Journal of Clinical and Translational Hepatology. 0(0). 0–0.

Li, Jiehan, Ge Zhang, Yizheng Zhang, et al.. (2025). Decreased M6A Modification Promotes Progression of Gastrointestinal Stromal Tumor and KIT‐Derived Imatinib Resistance Through FTO‐Regulated Axis. EUR Research Repository (Erasmus University Rotterdam). 4(4).

Li, Jiehan, Ning Ding, S. David Wu, et al.. (2025). SIRT6-Mediated Regulation of TFAM: A Central Mechanism Connecting Nuclear and Mitochondrial Transcriptional Processes and Mitophagy. International Journal of Biological Sciences. 22(1). 178–200. 1 indexed citations

Gao, Jianjun, Jiangang Wang, Xinlei Zou, et al.. (2024). Advances in Drug Therapy for Metastatic Pancreatic Ductal Adenocarcinoma. Journal of Cancer. 15(8). 2214–2228. 1 indexed citations

Li, Jiehan, et al.. (2024). Circular RNAs in Breast Cancer: An Update. Biomolecules. 14(2). 158–158. 5 indexed citations

Li, Jiehan, et al.. (2023). Circular RNAs in pancreatic cancer progression. Clinica Chimica Acta. 552. 117633–117633. 3 indexed citations

Li, Jiehan, et al.. (2023). Non-Coding RNA in Cholangiocarcinoma: An Update. Frontiers in Bioscience-Landmark. 28(8). 173–173. 7 indexed citations

10.

Zhang, Ge, Jiehan Li, Yizheng Zhang, et al.. (2023). Targeting AKT induced Ferroptosis through FTO/YTHDF2-dependent GPX4 m6A methylation up-regulating and degradating in colorectal cancer. Cell Death Discovery. 9(1). 457–457. 22 indexed citations

11.

Huang, Ziyue, Zhensheng Wang, Haoming Xia, et al.. (2022). Long noncoding RNA HAND2-AS1: A crucial regulator of malignancy. Clinica Chimica Acta. 539. 162–169. 4 indexed citations

12.

Zhao, Mingyi, et al.. (2022). 5-ALA mediated photodynamic therapy with combined treatment improves anti-tumor efficacy of immunotherapy through boosting immunogenic cell death. Cancer Letters. 554. 216032–216032. 41 indexed citations

13.

Liu, Nannan, Leiming Guo, Chuchu Zhang, et al.. (2022). Mutant p53 achieved Gain-of-Function by promoting tumor growth and immune escape through PHLPP2/AKT/PD-L1 pathway. International Journal of Biological Sciences. 18(6). 2419–2438. 14 indexed citations

14.

Li, Jiehan, et al.. (2022). Noncoding RNAs in Drug Resistance of Gastrointestinal Stromal Tumor. Frontiers in Cell and Developmental Biology. 10. 808591–808591. 6 indexed citations

15.

Almeida, Rodrigo Coutinho de, et al.. (2020). The miRNA‐mRNA interactome of murine induced pluripotent stem cell‐derived chondrocytes in response to inflammatory cytokines. The FASEB Journal. 34(9). 11546–11561. 14 indexed citations

16.

Tanigawa, Yosuke, Jiehan Li, Johanne Marie Justesen, et al.. (2019). Components of genetic associations across 2,138 phenotypes in the UK Biobank highlight adipocyte biology. Nature Communications. 10(1). 4064–4064. 39 indexed citations

17.

Li, Jiehan & Vassilios Papadopoulos. (2015). Translocator protein (18kDa) as a pharmacological target in adipocytes to regulate glucose homeostasis. Biochemical Pharmacology. 97(1). 99–110. 19 indexed citations

18.

Li, Jiehan, Vassilios Papadopoulos, & Veera Vihma. (2015). Steroid biosynthesis in adipose tissue. Steroids. 103. 89–104. 97 indexed citations

19.

Li, Jiehan, Edward Daly, Enrico Campioli, Martin Wabitsch, & Vassilios Papadopoulos. (2013). De Novo Synthesis of Steroids and Oxysterols in Adipocytes. Journal of Biological Chemistry. 289(2). 747–764. 78 indexed citations

20.

Campioli, Enrico, Amani Batarseh, Jiehan Li, & Vassilios Papadopoulos. (2011). The Endocrine Disruptor Mono-(2-Ethylhexyl) Phthalate Affects the Differentiation of Human Liposarcoma Cells (SW 872). PLoS ONE. 6(12). e28750–e28750. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact